Mizuho Upgrades Satsuma Pharmaceuticals to Buy, Raises Price Target to $15
Mizuho analyst Vamil Divan upgrades Satsuma Pharmaceuticals (NASDAQ:STSA) from Neutral to Buy and raises the price target from $7 to $15.
Oppenheimer Upgrades Lincoln Electric Holdings to Outperform, Announces $147 Price Target
Oppenheimer analyst Bryan Blair upgrades Lincoln Electric Holdings (NASDAQ:LECO) from Perform to Outperform and announces $147 price target.
Loop Capital Upgrades American Woodmark to Buy, Announces $100 Price Target
Loop Capital analyst Garik Shmois upgrades American Woodmark (NASDAQ:AMWD) from Hold to Buy and announces $100 price target.
Loop Capital Upgrades Fortune Brands Home to Buy, Announces $100 Price Target
Loop Capital analyst Garik Shmois upgrades Fortune Brands Home (NYSE:FBHS) from Hold to Buy and announces $100 price target.
Atlantic Equities Upgrades Ball to Overweight, Announces $101 Price Target
Atlantic Equities analyst Colin Isaac upgrades Ball (NYSE:BLL) from Neutral to Overweight and announces $101 price target.
Goldman Sachs Upgrades Delek US Hldgs to Neutral, Announces $24 Price Target
Goldman Sachs analyst Neil Mehta upgrades Delek US Hldgs (NYSE:DK) from Sell to Neutral and announces $24 price target.
Oppenheimer Upgrades Sally Beauty Holdings to Outperform, Announces $24 Price Target
Oppenheimer analyst Rupesh Parikh upgrades Sally Beauty Holdings (NYSE:SBH) from Perform to Outperform and announces $24 price target.
Stifel Upgrades CrowdStrike Holdings to Buy, Raises Price Target to $300
Stifel analyst Brad Reback upgrades CrowdStrike Holdings (NASDAQ:CRWD) from Hold to Buy and raises the price target from $240 to $300.
Bernstein Upgrades APA to Outperform, Raises Price Target to $35
Bernstein analyst Bob Brackett upgrades APA (NASDAQ:APA) from Market Perform to Outperform and raises the price target from $23 to $35.